108770 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Dendritic cells, e.g. Langherhans cells in the epidermis
Compositions and methods for combination therapy with dengue virus and dendritic cells
#302Compositions and Methods for Recombinant CXADR Expression
#303METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS
#304Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#305Methods for inducing migration by dendritic cells and an immune response
#306Generation of antigen-specific TCRs
#307Dendritic cell composition
#308Therapeutic cancer vaccines derived from a novel dendritic cell line
#309Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#310Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
#311METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF
#312BK virus specific T cells
#313METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#314Methods for generating engineered human primary blood dendritic cell lines
#315Methods for directed differentiation of pluripotent stem cells to immune cells
#316NKT CELL-ACTIVATION PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THEREOF AND METHOD OF STORING ANTIGEN PRESENTING CELL
#317Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#318Systems for producing cellular immunotherapeutics and methods of use thereof
#319Generation of HPV-specific T-cells
#320TRANSINFECTED LYMPHOCYTES FOR ANTI-TUMOR THERAPY
#321Tumor lysate loaded particles
#322DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS
#323Dendritic cell generator
#324Therapy and methods for introducing immature and dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
#325METHODS OF OBTAINING MONONUCLEAR BLOOD CELLS AND USES THEREOF
#326Method for generating human dendritic cells for immunotherapy
#327Delivery of biomolecules to immune cells
#328ENHANCING THE T-CELL STIMULATORY CAPACITY OF HUMAN ANTIGEN PRESENTING CELLS IN VITRO AND IN VIVO AND ITS USE IN VACCINATION
#329DENDRITIC CELL IMMUNOTHERAPY
#330Enrichment of CD16+ monocytes to improve dendritic cell vaccine quality
#331Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#332DENDRITIC CELL INHIBITORY PROTEINS FROM TICKS
#333MULTIPOTENT STEM CELLS AND USES THEREOF
#334MULTIPOTENT STEM CELLS AND USES THEREOF
#335FLUORESCENT DENDRITIC TAGS
#336Compositions and methods of treating cancer
#337METHOD FOR ANTIGEN LOADING OF DENDRITIC CELLS AND VACCINE
#338Methods of cancer treatment using activated T cells
#339METHOD FOR PREPARING DENDRITIC CELLS VIA NON-ADHESIVE CULTURE USING IFN
#340Multipotent stem cells and uses thereof
#341PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand
#342Compositions and methods for combination therapy with dengue virus and dendritic cells
#343Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
#344Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
#345Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient
#346Co-differentiation of monocytes from allogeneic donors
#347MULTIPOTENT STEM CELLS AND USES THEREOF
#348Tumor lysate loaded particles
#349Engineered Dendritic Cells and Uses for the Treatment of Cancer
#350Compositions and methods for combination therapy with dengue virus and dendritic cells
#351METHOD FOR PREPARING DENDRITIC CELL LOADED WITH ANTIGEN
#352Modulation of stimulatory and non-stimulatory myeloid cells
#353METHOD FOR THE CANCER TREATMENT AND PREVENTION OF METASTATIC DISEASE
#354EX VIVO DEVELOPMENT, EXPANSION AND IN VIVO ANALYSIS OF A NOVEL LINEAGE OF DENDRITIC CELLS
#355Cell population for use in treating cancer
#356Cancer vaccine composition
#357Methods and compositions for modulating peripheral immune function
#358MANUFACTURING OF MULTI-DOSE INJECTION READY DENDRITIC CELL VACCINES, COMBINATION THERAPIES FOR BLOCKING HER2 AND HER3, AND ESTROGEN RECEPTOR POSITIVE HER2 BREAST RECEPTOR POSITIVE HER2 BREAST CANCER THERAPY
#359Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same
#360PERSONALIZED CANCER VACCINES AND METHODS THEREFOR
#361Method for preparing dendritic cell, dendritic cell prepared thereby, and use thereof
#362A METHOD TO UP-REGULATE CANCER STEM CELL MARKERS FOR THE GENERATION OF ANTIGEN SPECIFIC CYTOTOXIC EFFECTOR T CELLS
#363Cancer vaccines and vaccination methods
#364Use of Mcoln-1 modulators to regulate cell migration
#365Treatment or prevention of melanoma using photochemical internalization of a melanoma antigen
#366Dendritic cell immune receptor activator, method for activating dendritic cell immune receptor, osteoclast formation inhibitor, method for inhibiting osteoclast formation, dendritic cell differentiation/proliferation inhibitor, method for inhibiting dendritic cell differentiation/proliferation, cytokine production inhibitor, method for inhibiting cytokine production, therapeutic method and screening method
#367ORGANOIDS COMPRISING DECELLULARIZED AND REPOPULATED PLACENTAL VASCULAR SCAFFOLD
#368Method for obtaining globally activated monocytes
#369Multi-lineage hematopoietic precursor cell production by genetic programming
#370ANTIGEN SPECIFIC TOLEROGENIC ANTIGEN PRESENTING CELLS AND RELATED USES COMPOSITIONS, METHODS AND SYSTEMS
#371β-glucan methods and compositions that affect the tumor microenvironment
#372Mature dendritic cell compositions and methods for culturing same
#373Mature dendritic cell compositions and methods for culturing same
#374Compositions and methods for producing dendritic cells
#375MULTI-CHAMBER CULTURE VESSEL AND CELL CULTURING METHOD
#376COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS
#377Method for proliferation of antigen-specific T cells
#378Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#379GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#380Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#381Protein markers associated bone marrow stem cell differentiation into early progentior cells
#382ENHANCING THE T-CELL STIMULATORY CAPACITY OF HUMAN ANTIGEN PRESENTING CELLS IN VITRO AND IN VIVO AND ITS USE IN VACCINATION
#383Compositions and methods for combination therapy with dengue virus and dendritic cells
#384Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#385CANCER VACCINE COMPOSITION
#386Pharmaceutical containing dendritic cells, and method for producing same
#387Granulysin in immunotherapy
#388Somatic stem cells
#389METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT
#390Galactose oxidase treatment of dendritic cells to improve their immunogenicity
#391METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS
#392HMGN POLYPEPTIDES AS IMMUNE ENHANCERS AND HMGN ANTAGONISTS AS IMMUNE SUPPRESSANTS
#393DENDRITIC CELL MODULATORY MOLECULE
#394Methods and compositions related to T-1 dendritic cells
#395MULTIPOTENT STEM CELLS AND USES THEREOF
#396Compositions, methods and kits for eliciting an immune response
#397COMPOSITE TISSUE CANCER VACCINE
#398Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
#399Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#400IMMUNOTHERAPY USING STEM CELLS
#401METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS
#402Immunity-inducing agent
#403Dendritic Cell Compositions and Methods
#404Tolerogenic dendritic cells for treating myocardial infarction and manufacturing method thereof
#405DENDRITIC CELL TUMOR VACCINE AND METHOD FOR PREPARING THE SAME
#406HIGH PURITY OVARIAN CANCER STEM CELLS FOR ACTIVE AUTOLOGOUS IMMUNE THERAPY
#407Cancer vaccines and vaccination methods
#408Method for treating cancers with dendritic killer cells and pharmaceutical composition comprising the same
#409METHOD
#410Induced dendritic cells and uses thereof
#411Individualized High Purity Glioblastoma Multiforme Stem Cells and Methods for Stimulating Immune Response
#412Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#413Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
#414GENERATION OF FUNCTIONAL DENDRITIC CELLS
#415Methods and compositions for treating breast cancer with dendritic cell vaccines
#416Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use
#417OVARIAN CANCER VACCINES AND VACCINATION METHODS
#418Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
#419Somatic stem cells
#420Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
#421Co-differentiation of monocytes from allogeneic donors
#422Method of inducing an immune response by administering WDRPUH epitope peptides
#423Allogenic mesendritic vector for ovarian cancer
#424Therapeutic cancer vaccines derived from a novel dendritic cell line
#425Pharmaceutical composition for preventing or treating cancers comprising dendritic cells with Dab2 gene silenced
#426In vitro generation of dendritic cells by exposure to an anti-CSF1-R antibody
#427Method for obtaining monocytes or NK cells
#428COMPOSITION INCLUDING GELSOLIN AS EFFECTIVE INGREDIENT FOR INDUCING DIFFERENTIATION INTO DENDRITIC CELL AND METHOD OF INDUCING DIFFERENTIATION INTO DENDRITIC CELL
#429METHOD FOR LOADING OF DENDRITIC CELLS WITH CLASS I ANTIGENS
#430Methods for inducing migration by dendritic cells and an immune response
#431Methods of evaluating immunogenicity of an agent using an artificial tissue construct
#432METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS
#433Dendritic Cell Compositions and Methods
#434Methods for Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom, and Uses Thereof
#435Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same
#436METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINES
#437Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#438Water extract of for immunostimulatory effect and preparation method thereof
#439Antigen composition, preparation method and use thereof, and tumor vaccine
#440Method for increasing the proportion of animal cells secreting galectin-9
#441METHOD FOR GENERATION OF CONDITIONALLY IMMORTALIZED HEMATOPOIETIC PROGENITOR CELL LINES WITH MULTIPLE LINEAGE POTENTIAL
#442Therapy and methods of introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
#443Mature dendritic cell compositions and methods for culturing same
#444Activated Immunostimulatory Cell Composition and Uses Thereof
#445Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
#446Immunomodulatory conjugates
#447Granulysin in immunotherapy
#448Compositions and methods for modulating myeloid derived suppressor cells
#449Compositions and methods for immunomodulation
#450Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
#451Compositions for the preparation of mature dendritic cells
#452Protein markers associated bone marrow stem cell differentiation into early progentior cells
#453Methods and composition related to Th-1 dendritic cells
#454Methods and compositions for modulating peripheral immune function
#455Methods for testing an immune response using cultures of T cells, B cells, dendritic cells and follicular dendritic cells
#456Composition containing complex cytokines derived from EBV-infected B cells for inducing the maturation of dendritic cells
#457Method for using directing cells for specific stem/progenitor cell activation and differentiation
#458Methods and compositions for expanding cells and improving engraftment
#459Compositions and methods to immunize against hepatitis C virus
#460MPHOSPH1 peptides and vaccines including the same
#461Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#462Method for expanding monocytes
#463Method for proliferation of antigen-specific T cells
#464Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#465MEANS AND METHODS FOR ACTIVE CELLULAR IMMUNOTHERAPY OF CANCER BY USING TUMOR CELLS KILLED BY HIGH HYDROSTATIC PRESSURE AND DENDRITIC CELLS
#466METHOD FOR ACTIVATION TREATMENT OF ANTIGEN-PRESENTING CELL
#467Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
#468Tumor lysate loaded particles
#469TUMOR LYSATE LOADED PARTICLES
#470Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination
#471Method for generating potent dendritic cells
#472Dendritic cells obtained from induced pluripotent stem cells (iPSCs)
#473Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor
#474Mature dendritic cell compositions and methods for culturing same
#475Formulation for cultivating dendritic killer cells and method using the same
#476Method for Treating Cancers with Dendritic Killer Cells and Pharmaceutical Composition
#477METHOD OF USING CD1D OVER-EXPRESSION IN HUMAN DENDRITIC CELLS TO ENHANCE CD8+ T CELL-BASED AND INVARIANT NATURAL KILLER T CELL-BASED ANTITUMOR IMMUNITY
#478Method for producing dendritic cells from pluripotent stem cells
#479Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
#480Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#481GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#482Method of inducing an immune response by administering WDRPUH epitope peptides
#483Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
#484Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#485Dendritic Cell Compositions and Methods
#486Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#487Compositions and methods for inducing migration by dendritic cells and an immune response
#488Somatic stem cells
#489Somatic stem cells
#490Method of forming dendritic cells from embryonic stem cells
#491Compositions and methods for producing dendritic cells
#492INDUCED DENDRITIC CELL COMPOSITIONS AND USES THEREOF
#493Method of producing myeloid blood cells
#494Derivation of hematopoietic cells from adult mesenchymal stem cells
#495System and Method of Preparing and Storing Activated Mature Dendritic Cells
#496Cancer vaccines and vaccination methods
#497Method for producing dendritic cells
#498Compositions and Methods for Enhancing Dendritic Cell Resistance to Bacterial Infection and for Enhancing the Mobility of Dendritic Cells for Dendritic Cell-Based Immunotherapy
#499Dendritic cell inhibitory proteins from ticks
#500Engineered dendritic cells and uses for the treatment of cancer
#501Platform of dendritic cell (DC)-based vaccination
#502Interferon-alpha-producing bone marrow dendritic cells
#503VACCINES WITH ONCOFETAL ANTIGEN/ILRP-LOADED AUTOLOGOUS DENDRITIC CELLS AND USES THEREOF
#504Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)
#505DENDRITIC CELL (DC)-VACCINE THERAPY FOR PANCREATIC CANCER
#506IMMUNE MODULATORS RELATING TO FOXO3A
#507SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONS
#508Composition for inhibiting tumor cell proliferation
#509SEPARATING MATERIAL AND METHOD FOR COLLECTING CELL OR THE LIKE USING THE SAME
#510INHIBITORS OF LL-37 MEDIATED IMMUNE REACTIVITY TO SELF NUCLEIC ACIDS
#511MUTZ-3 dendritic cells
#512Cryoconserved mature dendritic cells
#513COMPOSITIONS AND METHODS TO IMMUNIZE AGAINST HEPATITIS C VIRUS
#514Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
#515METHODS AND COMPOSITIONS FOR PRODUCING ANTIGENIC RESPONSES
#516Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#517HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
#518Mature Dendritic Cell Compositions and Methods of Culturing Same
#519ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS
#520Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems
#521COMPOSITIONS AND METHODS FOR INDUCING THE ACTIVATION OF IMMATURE MONOCYTIC DENDRITIC CELLS
#522Creating bioengineered lymph nodes
#523Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#524TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS
#525Granulysin in immunotherapy
#526METHOD OF PRODUCING A MEDICAL COMPOSITION
#527Immunity-inducing agent
#528Somatic stem cells
#529SEPARATING MATERIAL AND METHOD FOR COLLECTING CELL OR THE LIKE USING THE SAME
#530Cancer vaccines and vaccination methods
#531Method of forming dendritic cells from embryonic stem cells
#532Method for expanding monocytes
#533Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
#534Dendritic cell compositions and methods
#535Engineered Dendritic Cells and Uses for the Treatment of Cancer
#536DIFFERENTIATION OF PRIMATE PLURIPOTENT STEM CELLS TO HEMATOPOIETIC LINEAGE CELLS
#537DENDRITIC CELL MODULATORY MOLECULE
#538Methods for testing an immune response using cultures of T cells, B cells and dendritic cells
#539Method for producing dendritic cells
#540Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
#541Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
#542Plasmacytoid dendritic cell line used in active or adoptive cell therapy
#543Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof
#544Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#545PLATFORM OF DENDRITIC CELL (DC)-BASED VACCINATION
#546Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#547MULTIPOTENT STEM CELLS AND USES THEREOF
#548Methods and compositions related to T-1 dendritic cells
#549CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYER'S PATCHES AND USES THEREOF
#550WDRPUH epitope peptides and vaccines containing the same
#551Method for augmenting the immunogenicity of an antigen
#552IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
#553Methods for assaying responses to vaccines
#554USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES
#555Methods of evaluating an immune response to an antigen
#556METHODS FOR TREATING TUMORS AND CANCEROUS TISSUES
#557Dendritic cell vaccines
#558CDCA1 peptide and pharmaceutical agent comprising the same
#559Method for using directing cells for specific stem/progenitor cell activation and differentiation
#560Use of anti-cancer cell composition for treatment of head and neck cancer, which is intended to be administered to nutrient artery of tumor
#561Pairing processes for preparing reactive cytotoxic T cells
#562Method of forming myeloid precursor cells from human embryonic stem cells
#563Method for inducing and accelerating cells
#564Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
#565Dendritic Cells
#566Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
#567Dendritic cell vaccines for asparaginyl-β-hydroxylase expressing tumors
#568Cancer vaccine composition
#569Therapeutical composition containing dentritic cells and use thereof
#570Enhanced dendritic cells for cancer immunotherapy
#571Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids
#572METHODS RELATED TO IMMUNOSTIMULATORY NUCLEIC ACID-INDUCED INTERFERON
#573Pairing processes for preparing alloreactive cytotoxic T cells
#574Compositions and methods of preparing alloreactive cytotoxic T cells
#575Method for producing dendritic cells
#576GENERAL METHOD FOR GENERATING HUMAN ANTIBODY RESPONSES IN VITRO
#577IMMUNOMODULATORY POLYMERIC ANTIGENS FOR TREATING INFLAMMATORY PATHOLOGIES
#578EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES
#579METHOD FOR PRODUCING LANGERHANS CELLS OR INTERSTITIAL DENDRITIC CELLS OR BOTH FROM CD14+ MONOCYTES
#580Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
#581Modified Antigen Presenting Cells and Methods of Use
#582MULTIPOTENT STEM CELLS AND USES THEREOF
#583Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
#584Compositions for the preparation of mature dendritic cells
#585METHOD FOR MODIFYING CELLUAR IMMUNE RESONSE BY MODULATING ACTIVIN ACTIVITY
#586Dendritic cell precursors
#587Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#588WATER EXTRACT OF ANTRODIA CAMPHORATA FOR IMMUNOSTIMULATORY EFFECT AND PREPARATION METHOD THEREOF
#589Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
#590METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#591Microparticle-based transfection and activation of dendritic cells
#592Generation of antigen specific T cells
#593Method for production of dendritic cell
#594In vitro germinal centers
#595Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#596Cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS)
#597Method for determining the immunogenicity of an antigen
#598Methods and immunogenic cell preparations for treating antigen-associated diseases
#599NKT CELL-STIMULATING AGENT FOR ADMINISTRATION THROUGH UPPER RESPIRATORY TRACT MUCOUS MEMBRANE
#600POROUS MEMBRANE DEVICE THAT PROMOTES THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS